- Home
- PRMB vs ITCI Comparison
PRMB vs ITCI Comparison
Compare PRMB & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRMB
- ITCI
- Stock Information
- Founded
- PRMB 1955
- ITCI 2002
- Country
- PRMB United States
- ITCI United States
- Employees
- PRMB N/A
- ITCI N/A
- Industry
- PRMB
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- PRMB
- ITCI Health Care
- Exchange
- PRMB Nasdaq
- ITCI Nasdaq
- Market Cap
- PRMB 12.6B
- ITCI 13.5B
- IPO Year
- PRMB N/A
- ITCI N/A
- Fundamental
- Price
- PRMB $34.07
- ITCI $128.60
- Analyst Decision
- PRMB Strong Buy
- ITCI Buy
- Analyst Count
- PRMB 3
- ITCI 13
- Target Price
- PRMB $39.33
- ITCI $103.92
- AVG Volume (30 Days)
- PRMB 1.8M
- ITCI 2.2M
- Earning Date
- PRMB 02-20-2025
- ITCI 02-21-2025
- Dividend Yield
- PRMB 3.45%
- ITCI N/A
- EPS Growth
- PRMB N/A
- ITCI N/A
- EPS
- PRMB N/A
- ITCI N/A
- Revenue
- PRMB $5,152,500,000.00
- ITCI $613,728,000.00
- Revenue This Year
- PRMB N/A
- ITCI $48.28
- Revenue Next Year
- PRMB N/A
- ITCI $37.34
- P/E Ratio
- PRMB N/A
- ITCI N/A
- Revenue Growth
- PRMB 9.66
- ITCI 46.08
- 52 Week Low
- PRMB $15.31
- ITCI $63.30
- 52 Week High
- PRMB $34.53
- ITCI $128.77
- Technical
- Relative Strength Index (RSI)
- PRMB N/A
- ITCI 83.90
- Support Level
- PRMB N/A
- ITCI $126.88
- Resistance Level
- PRMB N/A
- ITCI $128.19
- Average True Range (ATR)
- PRMB 0.00
- ITCI 0.41
- MACD
- PRMB 0.00
- ITCI -1.30
- Stochastic Oscillator
- PRMB 0.00
- ITCI 91.01
About PRMB Primo Brands Corporation Class A Common Stock
Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and innovative brand packaging portfolio, which includes recycled plastic, aluminum, and glass.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.